WuXi Biologics issues new shares under share scheme
WuXi Biologics (Cayman) Inc. announced a change in its issued shares, according to a Next Day Disclosure Return filed with the Hong Kong Stock Exchange on April 10, 2025. The company issued 10,000 new ordinary shares under its Pre-IPO Share Option Scheme, which was adopted on January 5, 2016, and amended on August 10, 2016. These shares were issued at a price of HKD 4.67 per share. This issuance increased the total number of issued shares, excluding treasury shares, to 4,108,315,791. The company also reported it had previously repurchased 10,080,000 shares for cancellation at a price of HKD 19.78. The announcement confirmed that the share issuance was duly authorized and compliant with all applicable regulations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when WuXi Biologics (Cayman) Inc publishes news
Free account required • Unsubscribe anytime